These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1607547)

  • 1. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions.
    Proud D; Bailey GS; Naclerio RM; Reynolds CJ; Cruz AA; Eggleston PA; Lichtenstein LM; Togias AG
    J Allergy Clin Immunol; 1992 Jun; 89(6):1098-110. PubMed ID: 1607547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity.
    Juliusson S; Holmberg K; Baumgarten CR; Olsson M; Enander I; Pipkorn U
    Allergy; 1991 Aug; 46(6):459-65. PubMed ID: 1957995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response.
    Castells M; Schwartz LB
    J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):348-55. PubMed ID: 3049743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
    Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation.
    Zeng D; Prosperini G; Russo C; Spicuzza L; Cacciola RR; Di Maria GU; Polosa R
    J Allergy Clin Immunol; 2004 Aug; 114(2):316-20. PubMed ID: 15316509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. Evidence for epithelial cell involvement.
    Koskela H; Di Sciascio MB; Anderson SD; Andersson M; Chan HK; Gadalla S; Katelaris C
    Clin Exp Allergy; 2000 Nov; 30(11):1627-36. PubMed ID: 11069573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
    KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
    J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.
    Togias AG; Naclerio RM; Proud D; Fish JE; Adkinson NF; Kagey-Sobotka A; Norman PS; Lichtenstein LM
    J Clin Invest; 1985 Oct; 76(4):1375-81. PubMed ID: 2414318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.
    Mosimann BL; White MV; Hohman RJ; Goldrich MS; Kaulbach HC; Kaliner MA
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):95-104. PubMed ID: 7687608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose.
    Togias A; Lykens K; Kagey-Sobotka A; Eggleston PA; Proud D; Lichtenstein LM; Naclerio RM
    Am Rev Respir Dis; 1990 Jun; 141(6):1428-33. PubMed ID: 2112349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local application of atropine attenuates the upper airway reaction to cold, dry air.
    Cruz AA; Togias AG; Lichtenstein LM; Kagey-Sobotka A; Proud D; Naclerio RM
    Am Rev Respir Dis; 1992 Aug; 146(2):340-6. PubMed ID: 1489122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo release of inflammatory mediators by hyperosmolar solutions.
    Silber G; Proud D; Warner J; Naclerio R; Kagey-Sobotka A; Lichtenstein L; Eggleston P
    Am Rev Respir Dis; 1988 Mar; 137(3):606-12. PubMed ID: 2449834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.
    Russo C; Zeng D; Prosperini G; Spicuzza L; Guarino F; Polosa R
    Clin Exp Allergy; 2005 Sep; 35(9):1192-6. PubMed ID: 16164447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy and mast cell activation.
    Carlos AG; Carlos ML; Santos MA; Pedro E; Santos S; Lopes-Pregal A
    Allerg Immunol (Paris); 1998 Oct; 30(8):257-8. PubMed ID: 9846195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of mast cell degranulation in human allergic nasal epithelium after provocation with allergen.
    Kawabori S; Okuda M; Unno T; Nakamura A
    Clin Allergy; 1985 Nov; 15(6):509-15. PubMed ID: 2416488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial shedding is associated with nasal reactions to cold, dry air.
    Cruz AA; Naclerio RM; Proud D; Togias A
    J Allergy Clin Immunol; 2006 Jun; 117(6):1351-8. PubMed ID: 16750997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air.
    Togias AG; Proud D; Lichtenstein LM; Adams GK; Norman PS; Kagey-Sobotka A; Naclerio RM
    Am Rev Respir Dis; 1988 Mar; 137(3):625-9. PubMed ID: 2449835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air.
    Cruz AA; Togias AG; Lichtenstein LM; Kagey-Sobotka A; Proud D; Naclerio RM
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):761-5. PubMed ID: 1706910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.